Italian firm Cosmo Pharmaceuticals today announced a licensing
agreement with Ferring for its reformulated budesonide product,
predicted to be the first oral corticosteroid for ulcerative
colitis approved worldwide.
PDL Biopharma has seen a week of drama after announcing a
restructure that left its key investor calling for the company
chairman to resign, a week after its CEO also decided to step
down after similar pressure.